Cargando…
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
Autores principales: | Ogawa, Yoshihiko, Nagata, Toshihiko, Akiyama, Taisuke, Nishida, Koji, Kumasawa, Junji, Kohno, Michihiko, Kohata, Hisakazu, Gohma, Iwao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418284/ https://www.ncbi.nlm.nih.gov/pubmed/32780355 http://dx.doi.org/10.1007/s11239-020-02248-8 |
Ejemplares similares
-
Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010) -
Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020) -
Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021) -
Assessing the effects of exposure to a SARS-CoV-2 re-positive patient in healthcare personnel
por: Ogawa, Yoshihiko, et al.
Publicado: (2020) -
Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)